Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Joint Bone Spine Année : 2019

Dates et versions

hal-04445067 , version 1 (07-02-2024)

Identifiants

Citer

Julien Paccou, Maria Nachury, Cédric Duchemin, Pierre Desreumaux, René-Marc Flipo, et al.. Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease. Joint Bone Spine, 2019, 86 (5), pp.654-656. ⟨10.1016/j.jbspin.2019.01.008⟩. ⟨hal-04445067⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More